Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Background The first goal of the study was to analyse the antibody titre 7 days after the second dose of BNT162b2 vaccine in a group of 248 healthcare workers (HCW). The second goal was to analyse how the antibody titre changes in correlation with age, gender and BMI. Methods Participants were assigned to receive the priming dose at baseline and booster dose at day 21. Blood and nasopharyngeal swabs were collected at baseline and 7 days after second dose of vaccine. Findings 248 HWCs were analysed, 158 women (63.7%) and 90 men (36.3%). After the second dose of BNT162b2 vaccine, 99.5% of participants developed a humoral immune response. The geometric mean concentration of antibodies among the vaccinated subjects after booster dose (285.9 AU/mL 95% CI: 249.5-327.7); was higher than that of human convalescent sera (39.4 AU/mL, 95% CI: 33.1-46.9), with p<0.0001. The antibody titre was found to be higher in young and female participants. A strong correlation of BMI classes with antibody titres was noticed: humoral response was more efficient in the group with under- and normal-weight vs the group with pre- and obesity participants (p<0.0001 at T1). Interpretation These findings imply that females, lean and young people have an increased capacity to mount humoral immune responses compared to males, overweight and the older population. Although further studies are needed, this data may have important implications for the development of vaccination strategies for COVID-19, particularly in obese people. Funding None
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 1×
“The same study showed that safety over a median of 2 months was similar to that of other viral vaccines [2].”
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655 · cited 1×
“The constant state of low-grade inflammation, present in overweight people, can weaken some immune responses, including those launched by T cells, which can directly kill infected cells [25].”
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
Walsh, E. E., Frenck, R., Falsey, A. R., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Mulligan, M. J., Bailey, R., et al. (2020) · doi:10.1101/2020.08.17.20176651 · Cited by 2,615
Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
Peckham, H., de Gruijter, N. M., Raine, C., Radziszewska, A., Ciurtin, C., Wedderburn, L. R., Rosser, E. C., Webb, K., & Deakin, C. T. (2020) · Nature Communications · doi:10.1038/s41467-020-19741-6 · Cited by 1,503 · cited 1×
“Male patients have almost three times the odds of necessitating intensive treatment unit admission and higher odds of death compared to females [16].”
Popkin, B. M., Du, S., Green, W. D., Beck, M. A., Algaith, T., Herbst, C. H., Alsukait, R. F., Alluhidan, M., Alazemi, N., & Shekar, M. (2020) · Obesity Reviews · doi:10.1111/obr.13128 · Cited by 1,150
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Sahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L. M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., Baum, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03653-6 · Cited by 919
BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans
Sahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L. M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., Baum, A., et al. (2020) · doi:10.1101/2020.12.09.20245175 · Cited by 914
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Chandrashekar, A., Liu, J., Martinot, A. J., McMahan, K., Mercado, N. B., Peter, L., Tostanoski, L. H., Yu, J., Maliga, Z., Nekorchuk, M., et al. (2020) · Science · doi:10.1126/science.abc4776 · Cited by 816 · cited 1×
“To overcome this limit, antibody titre can be used to predict protection against SARS-CoV-2, as already done for many viruses in humans and for SARS-CoV-2 in animal challenges [3, 4].”
Rubtsov, A. V., Rubtsova, K., Fischer, A., Meehan, R. T., Gillis, J. Z., Kappler, J. W., & Marrack, P. (2011) · Blood · doi:10.1182/blood-2011-01-331462 · Cited by 808 · cited 1×
“Additional qualitative change with age is the expansion of a pro-inflammatory subset of B cell similar to age-associated B cells (ABCs) described in mice [13, 14].”
A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice
Hao, Y., O'Neill, P., Naradikian, M. S., Scholz, J. L., & Cancro, M. P. (2011) · Blood · doi:10.1182/blood-2011-01-330530 · Cited by 622 · cited 1×
“Additional qualitative change with age is the expansion of a pro-inflammatory subset of B cell similar to age-associated B cells (ABCs) described in mice [13, 14].”
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans
Hagan, T., Cortese, M., Rouphael, N., Boudreau, C., Linde, C., Maddur, M. S., Das, J., Wang, H., Guthmiller, J., Zheng, N.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.010 · Cited by 572
Sex and Gender Differences in the Outcomes of Vaccination over the Life Course
Flanagan, K. L., Fink, A. L., Plebanski, M., & Klein, S. L. (2017) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100616-060718 · Cited by 508 · cited 1×
“Women produce higher antibody titres in response to the trivalent inactivated seasonal in fl uenza vaccination (TIV) [17, 18], as well as to most other pathogen vaccines [19].”
Obesity as a Predictor of Poor Antibody Response to Hepatitis B Plasma Vaccine
Weber, D. J. (1985) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1985.03360220053027 · Cited by 345 · cited 1×
“Moreover, vaccines against influenza [27], hepatitis B [28], rabies [29] and tetanus [30] have shown reduced responses in those who have obesity compared with those who are lean.”
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Drucker, D. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.016 · Cited by 272 · cited 1×
“Since obesity is a major risk factor for morbidity and mortality for patients with COVID-19 [22], it is mandatory to plan an efficient vaccination program in this subgroup [23, 24].”
Obesity decreases B cell responses in young and elderly individuals
Frasca, D., Ferracci, F., Diaz, A., Romero, M., Lechner, S., & Blomberg, B. B. (2016) · Obesity · doi:10.1002/oby.21383 · Cited by 228 · cited 1×
“Moreover, vaccines against influenza [27], hepatitis B [28], rabies [29] and tetanus [30] have shown reduced responses in those who have obesity compared with those who are lean.”
Reduced tetanus antibody titers in overweight children
Eliakim, A., Swindt, C., Zaldivar, F., Casali, P., & Cooper, D. M. (2006) · Autoimmunity · doi:10.1080/08916930600597326 · Cited by 209 · cited 1×
“Moreover, vaccines against influenza [27], hepatitis B [28], rabies [29] and tetanus [30] have shown reduced responses in those who have obesity compared with those who are lean.”
Frasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.04.023 · Cited by 144
Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans
Frasca, D., Diaz, A., Romero, M., Landin, A. M., Phillips, M., Lechner, S. C., Ryan, J. G., & Blomberg, B. B. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.023 · Cited by 143 · cited 1×
“This included class switch recombination and differentiation in to plasmacells [11, 12].”
Krammer, F., Srivastava, K., the PARIS team, & Simon, V. (2021) · doi:10.1101/2021.01.29.21250653 · Cited by 116
Verschoor, C. P., Singh, P., Russell, M. L., Bowdish, D. M. E., Brewer, A., Cyr, L., Ward, B. J., & Loeb, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131531 · Cited by 99 · cited 2×
“…is under investigation, measurement of serum neutralizing activity has been demonstrated to correlate with protection for other respiratory viruses, such as in fl uenza [3] or respiratory syncytial virus [7] and is commonly accepted to be a functional biomarker of in vivo disease protection [8].”
Kulkarni, P. S., Hurwitz, J. L., Simões, E. A. F., & Piedra, P. A. (2018) · Viral Immunology · doi:10.1089/vim.2017.0147 · Cited by 53 · cited 1×
“Although the role of neutralizing antibodies to SARS-CoV-2 is under investigation, measurement of serum neutralizing activity has been demonstrated to correlate with protection for other respiratory viruses, such as influenza [3] or respiratory syncytial virus [7] and is”
Cited by
Watanabe, M., Balena, A., Tuccinardi, D., Tozzi, R., Risi, R., Masi, D., Caputi, A., Rossetti, R., Spoltore, M. E., Filippi, V., et al. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3465 · Cited by 266
Romero-Ibarguengoitia, M. E., Rivera-Salinas, D., Hernández-Ruíz, Y. G., Armendariz-Vázquez, A. G., González-Cantú, A., Barco-Flores, I. A., González-Facio, R., Montelongo-Cruz, L. P., Del Rio-Parra, G. F., Garza-Herrera, M. R., et al. (2021) · doi:10.1101/2021.10.20.21265269 · Cited by 29
Metadata
- Authors
- Pellini, R., Venuti, A., Pimpinelli, F., Abril, E., Blandino, G., Campo, F., Conti, L., De Virgilio, A., De Marco, F., Di Domenico, E. G., Di Bella, O., Di Martino, S., Ensoli, F., Giannarelli, D., Mandoj, C., Manciocco, V., Marchesi, P., Mazzola, F., Moretto, S., Petruzzi, G., Petrone, F., Pichi, B., Pontone, M., Zocchi, J., Vidiri, A., Vujovic, B., Piaggio, G., Morrone, A., & Ciliberto, G.
- Venue
- EClinicalMedicine
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 36
- Pages
- 100928
- ISSN
- 2589-5370 (ISSN-L)
- OpenAlex
- W3167263725
- Cited by
- 232
- References
- 22
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.